Massively parallel sequencing approaches such as WES have elucidated the landscape of genetic alterations in many tumor types and revealed biological insights relevant to clinical contexts 1. The ...
ST. LOUIS, Sept. 9, 2025 /PRNewswire/ -- Panome Bio, a leading provider of multi-omic services, announced a first of its kind commercial offering applying their leading discovery metabolomics ...